Risk factors for adverse drug reactions: epidemiological approaches
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel ; Boston ; Berlin
Birkhäuser
1990
|
Schriftenreihe: | Agents and actions
Supplements ; 29 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 149 S. |
ISBN: | 3764323728 0817623728 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV002472368 | ||
003 | DE-604 | ||
005 | 19900319 | ||
007 | t | ||
008 | 891211s1990 gw |||| 00||| eng d | ||
020 | |a 3764323728 |9 3-7643-2372-8 | ||
020 | |a 0817623728 |9 0-8176-2372-8 | ||
035 | |a (OCoLC)20853406 | ||
035 | |a (DE-599)BVBBV002472368 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c DE | ||
049 | |a DE-12 |a DE-20 |a DE-188 | ||
050 | 0 | |a RM302.5 | |
082 | 0 | |a 615/.7042 |2 20 | |
245 | 1 | 0 | |a Risk factors for adverse drug reactions |b epidemiological approaches |c [this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ... |
264 | 1 | |a Basel ; Boston ; Berlin |b Birkhäuser |c 1990 | |
300 | |a 149 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Agents and actions : Supplements |v 29 | |
650 | 4 | |a Médicaments - Effets secondaires | |
650 | 4 | |a Drugs |x Side effects | |
650 | 4 | |a Pharmaceutical Preparations |x adverse effects |v Congresses | |
650 | 4 | |a Risk Factors |v Congresses | |
650 | 0 | 7 | |a Risikofaktor |0 (DE-588)4050131-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Heidelberg |2 gnd-content | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Mannheim |2 gnd-content | |
689 | 0 | 0 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
689 | 0 | 1 | |a Risikofaktor |0 (DE-588)4050131-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 1 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Weber, Ellen |e Sonstige |4 oth | |
830 | 0 | |a Agents and actions |v Supplements ; 29 |w (DE-604)BV001899350 |9 29 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001596184&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-001596184 |
Datensatz im Suchindex
_version_ | 1804116884010827776 |
---|---|
adam_text | RISK FACTORS FOR ADVERSE DRUG REACTIONS EPIDEMIOLOGICAL APPROACHES
EDITED BY E. WEBER D. H. LAWSON R. HOIGNE 1990 BIRKHAUSER VERLAG BASEL *
BOSTON * BERLIN TABLE OF CONTENTS LIST OF SPEAKERS INTRODUCTORY REMARKS
E. WEBER FULL-LENGTH PAPERS OLD AGE - IS IT A RISK FACTOR FOR ADVERSE
DRUG REACTIONS? J. H. GURWITZ AND J. AVORN 13 GASTROINTESTINAL BLEEDING
FROM THE NONSTEROIDAL AN T I - I NF LAMMA TORY DRUGS B. L. STROM, M. I.
TARAGIN AND J. L. CARSON 27 TIME PATTERN OF ALLERGIC REACTIONS TO DRUGS
R. HOIGNE, M. D ANDREA JAEGER, R. WYMANN, A. EGLI, U. MULLER, T. HESS,
R. GALEAZZI, :; R. MAIBACH AND U. P. KUNZI . . . . . 39 DRUG DEVELOPMENT
OPTIMIZATION - BENZODIAZEPINES M. H. LADER . . . . . 59 EXTRAPYRAMIDAL
SYMPTOMS IN NEUROLEPTIC RECIPIENTS R. GROHMANN, R.KOCH AND L.G.SCHMIDT
71 EPIDEMIOLOGICAL SCREENING FOR POTENTIALLY CARCINOGENIC DRUGS G. D.
FRIEDMAN AND J. V. SELBY 83 TABLE OF CONTENTS (CONTINUED) SHORT
COMMUNICATIONS MONITORING FOR ADVERSE PREGNANCY OUTCOMES RELATED TO DRUG
EXPOSURE DURING PREGNANCY E. ANDREWS AND P. TENNIS 99 A TWENTY-YEAR
FOLLOW-UP STUDY ON PHENACETIN ABUSE U. C. DUBACH . . . . 101 PHYSICIAN S
COMPLIANCE U. C. DUBACH . . . . 103 COMPLIANCE WITH SHORT-TERM HIGH-DOSE
ETHINYL OESTRA- DIOL IN YOUNG PATIENTS WITH PRIMARY INFERTILITY: NEW
INSIGHTS FROM THE USE OF ELECTRONIC DEVICES W. KRUSE, W. EGGERT-KRUSE,
J. RAMPMAIER, B. RUNNEBAUM AND E.WEBER . . . . 105 RISK FACTORS AS
REFLECTED BY AN INTENSIVE DRUG MONITORING SYSTEM T. JACUBEIT, D. DRISCH
AND E.WEBER . . . . 117 PANEL DISCUSSION D. H. LAWSON (MODERATOR), R.
BRUPPACHER, M. N. G. DUKES AND G. R. VENNING . . . . 129
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV002472368 |
callnumber-first | R - Medicine |
callnumber-label | RM302 |
callnumber-raw | RM302.5 |
callnumber-search | RM302.5 |
callnumber-sort | RM 3302.5 |
callnumber-subject | RM - Therapeutics and Pharmacology |
ctrlnum | (OCoLC)20853406 (DE-599)BVBBV002472368 |
dewey-full | 615/.7042 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.7042 |
dewey-search | 615/.7042 |
dewey-sort | 3615 47042 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02131nam a2200517 cb4500</leader><controlfield tag="001">BV002472368</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19900319 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">891211s1990 gw |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3764323728</subfield><subfield code="9">3-7643-2372-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0817623728</subfield><subfield code="9">0-8176-2372-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)20853406</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002472368</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM302.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.7042</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Risk factors for adverse drug reactions</subfield><subfield code="b">epidemiological approaches</subfield><subfield code="c">[this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; Boston ; Berlin</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">149 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Agents and actions : Supplements</subfield><subfield code="v">29</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Effets secondaires</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">adverse effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Heidelberg</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Mannheim</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber, Ellen</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Agents and actions</subfield><subfield code="v">Supplements ; 29</subfield><subfield code="w">(DE-604)BV001899350</subfield><subfield code="9">29</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001596184&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001596184</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1989 Heidelberg gnd-content (DE-588)1071861417 Konferenzschrift 1989 Mannheim gnd-content |
genre_facet | Konferenzschrift 1989 Heidelberg Konferenzschrift 1989 Mannheim |
id | DE-604.BV002472368 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T15:45:36Z |
institution | BVB |
isbn | 3764323728 0817623728 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001596184 |
oclc_num | 20853406 |
open_access_boolean | |
owner | DE-12 DE-20 DE-188 |
owner_facet | DE-12 DE-20 DE-188 |
physical | 149 S. |
publishDate | 1990 |
publishDateSearch | 1990 |
publishDateSort | 1990 |
publisher | Birkhäuser |
record_format | marc |
series | Agents and actions |
series2 | Agents and actions : Supplements |
spelling | Risk factors for adverse drug reactions epidemiological approaches [this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ... Basel ; Boston ; Berlin Birkhäuser 1990 149 S. txt rdacontent n rdamedia nc rdacarrier Agents and actions : Supplements 29 Médicaments - Effets secondaires Drugs Side effects Pharmaceutical Preparations adverse effects Congresses Risk Factors Congresses Risikofaktor (DE-588)4050131-0 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 Heidelberg gnd-content (DE-588)1071861417 Konferenzschrift 1989 Mannheim gnd-content Arzneimittelnebenwirkung (DE-588)4003134-2 s Risikofaktor (DE-588)4050131-0 s DE-604 Chemotherapie (DE-588)4127083-6 s Weber, Ellen Sonstige oth Agents and actions Supplements ; 29 (DE-604)BV001899350 29 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001596184&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Risk factors for adverse drug reactions epidemiological approaches Agents and actions Médicaments - Effets secondaires Drugs Side effects Pharmaceutical Preparations adverse effects Congresses Risk Factors Congresses Risikofaktor (DE-588)4050131-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Chemotherapie (DE-588)4127083-6 gnd |
subject_GND | (DE-588)4050131-0 (DE-588)4003134-2 (DE-588)4127083-6 (DE-588)1071861417 |
title | Risk factors for adverse drug reactions epidemiological approaches |
title_auth | Risk factors for adverse drug reactions epidemiological approaches |
title_exact_search | Risk factors for adverse drug reactions epidemiological approaches |
title_full | Risk factors for adverse drug reactions epidemiological approaches [this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ... |
title_fullStr | Risk factors for adverse drug reactions epidemiological approaches [this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ... |
title_full_unstemmed | Risk factors for adverse drug reactions epidemiological approaches [this symposium was sponsored by: Abbott ...]. Ed. by E. Weber ... |
title_short | Risk factors for adverse drug reactions |
title_sort | risk factors for adverse drug reactions epidemiological approaches |
title_sub | epidemiological approaches |
topic | Médicaments - Effets secondaires Drugs Side effects Pharmaceutical Preparations adverse effects Congresses Risk Factors Congresses Risikofaktor (DE-588)4050131-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Chemotherapie (DE-588)4127083-6 gnd |
topic_facet | Médicaments - Effets secondaires Drugs Side effects Pharmaceutical Preparations adverse effects Congresses Risk Factors Congresses Risikofaktor Arzneimittelnebenwirkung Chemotherapie Konferenzschrift 1989 Heidelberg Konferenzschrift 1989 Mannheim |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001596184&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV001899350 |
work_keys_str_mv | AT weberellen riskfactorsforadversedrugreactionsepidemiologicalapproaches |